BeCapio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

BeCapio General Information

Description

Developer of a wearable fecal incontinence prevention device designed to address motility disorders. The company's device is based on a mechanical concept combined with electrical stimulation to deal with fecal incontinence disorder by providing a discrete, immediate, non-invasive, multi-modal, and inclusive therapy, enabling patients to regain control and maintain everyday activities.

Contact Information

Website
www.becapio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • T'chelet 17
  • Misgav Business Park
  • Tel Aviv 2017400
  • Israel
+972
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Corporate Office
  • T'chelet 17
  • Misgav Business Park
  • Tel Aviv 2017400
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BeCapio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Jul-2026 Completed Product Development
3. Accelerator/Incubator 27-May-2026 Completed Product Development
2. Accelerator/Incubator 24-Apr-2024 Completed Startup
1. Seed Round 01-Sep-2023 Completed Startup
To view BeCapio’s complete valuation and funding history, request access »

BeCapio Patents

BeCapio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024380796-A1 Device for treatment of fecal incontinence, and method thereof Pending 15-Nov-2023
EP-4808497-A1 Device for treatment of fecal incontinence, and method thereof Pending 15-Nov-2023
WO-2025104736-A1 Device for treatment of fecal incontinence, and method thereof Inactive 15-Nov-2023
US-12649058-B2 Transcutaneous electrical stimulator for treatment of fecal incontinence Active 21-Jun-2021
US-20240123224-A1 Transcutaneous electrical stimulator for treatment of fecal incontinence Active 21-Jun-2021 A61N1/36007
To view BeCapio’s complete patent history, request access »

BeCapio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BeCapio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Nexus Accelerator/Incubator
MedTech Innovator Accelerator/Incubator
SHAAR Accelerator/Incubator
Innovation Authority Government Minority
Trendlines Corporation Minority
To view BeCapio’s complete investors history, request access »

BeCapio FAQs

  • When was BeCapio founded?

    BeCapio was founded in 2022.

  • Where is BeCapio headquartered?

    BeCapio is headquartered in Tel Aviv, Israel.

  • What is the size of BeCapio?

    BeCapio has 4 total employees.

  • What industry is BeCapio in?

    BeCapio’s primary industry is Therapeutic Devices.

  • Is BeCapio a private or public company?

    BeCapio is a Private company.

  • What is BeCapio’s current revenue?

    The current revenue for BeCapio is .

  • Who are BeCapio’s investors?

    Innovation Nexus, MedTech Innovator, SHAAR, Innovation Authority, and Trendlines have invested in BeCapio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process